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Abstract
Background: Microvascular alterations contribute to the development of stroke and vascular
dementia. The goal of this study was to evaluate age and hypertension related changes of the basal
lamina in cerebral microvessels of individuals, who died from non-cerebral causes.
Results: We examined 27 human brains: 11 young and 16 old patients. Old patients were divided
into two subgroups, those with hypertension (n = 8) and those without hypertension (n = 8). Basal
lamina changes of the cerebral microvessels were determined in the putamen using antibodies
against collagen type IV and by quantitative analysis of vessel number, total stained area of collagen,
thickness of the vessel wall and lumen, and relative staining intensity using immunofluorescence.
The total number of collagen positive vessels per microscopic field was reduced in old compared
to young subjects (12.0+/-0.6 vs. 15.1+/-1.2, p = 0.02). The relative collagen content per vessel
(1.01+/-0.06 vs. 0.76+/-0.05, p = 0.01) and the relative collagen intensity (233.1+/-4.5 vs. 167.8+/-
10.6, p < 0.0001) shown by immunofluorescence were higher in the older compared to the younger
patients with a consecutive reduction of the lumen / wall ratio (1.29+/-0.05 vs. 3.29+/-0.15, p <
0.0001). No differences were observed for these parameters between old hypertensive and non-
hypertensive patients.
Conclusions: The present data show age-related changes of the cerebral microvessels in sections
of human putamen for the first time. Due to the accumulation of collagen, microvessels thicken and
show a reduction in their lumen. Besides this, the number of vessels decreases. These findings might
represent a precondition for the development of vascular cognitive impairment. However,
hypertension was not proven to modulate these changes.
Background
Aging is associated with a deterioration of cognitive func-
tion including a decrease in the ability to process and store
new information [1]. Processes that might negatively
affect cognitive function during aging are manifold.
Among them, the cerebral vascular system has a major
impact on brain function. Craigie first described that the
density of cerebral microvessels may correlate with
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functional activity [2]. However, morphological studies of
the microvessels have been inconsistent up to now. Meier-
Ruge and coworkers reported an increase in capillary den-
sity in older individuals [3], whereas others had shown a
reduction [4]. One important reason for the different find-
ings in microvascular changes might be the heterogeneity
of the examined brain regions between, but also within
the studies. Nevertheless changes in the cerebral microves-
sels have a major impact on secondary pathophysiological
changes, like reduced cerebral blood flow (CBF) [5,6], and
a decrease in doppler sonographic blood flow velocity in
old age [7]. In addition, microvascular alterations are
responsible for reduced cerebral metabolic rates for oxy-
gen and cerebral glucose utilization, which is observed
with increasing age [8,9] leading to an impaired transport
of nutrients which in turn impairs neuronal function.
Additional factors such as chronic hypertension may
accelerate the progression of age-related capillary changes
[10].
Although changes of cerebral vessels with aging and
hypertension have been reported, there are presently no
consistent data on the microvascular basal lamina. The
aim of our study was an evaluation of age-related changes
on cerebral microvessels and on the vascular extracellular
matrix in humans and the possible impact of chronic
hypertension using several different immunohistochemi-
cal methods for the detection of collagen type IV.
Results
Determination of collagen type IV in microvessels by 
immunohistochemistry
Old patients (OP) showed 12.0 +/- 0.6 vessels per micro-
scopic field, and young patients (YP) exhibited 15.1 ± 1.2
vessels per microscopic field (p = 0.02). The total area of
collagen type IV positive vessels did not differ between OP
and YP (11.0 ± 0.5 vs. 11.4 ± 0.6, n.s.). Therefore the cal-
culated content of collagen type IV per vessel was higher
in OP than in YP (1.01 ± 0.06 vs. 0.76 ± 0.05, p = 0.01).
No differences were observed between old non hyperten-
sive patients (ONHP) and old hypertensive patients
(OHP) (vessels per microscopic field: 11.3 ± 1.1 in ONHP
vs. 12.7 ± 0.7 in OHP, n.s.; area of collagen type IV: 12.1
± 0.8 in ONHP vs. 10.6 ± 0.9 in OHP, n.s.; calculated con-
tent of collagen type IV per vessel: 1.11 ± 0.1 in ONHP vs.
0.91 ± 0.07 in OHP, n.s.).
Thickness of vessel wall and lumen
Microvessel wall thickness, inner lumen and ratio lumen/
wall thickness were statistically different in OP vs. YP. The
vessel wall was thicker in old than in young patients (3.14
± 0.10 µm vs. 1.62 ± 0.06 µm, p < 0.0001). In addition the
vessel lumen was reduced in the old group compared to
the young group (4.00 ± 0.14 µm vs. 5.24 ± 0.13 µm, p <
0.0001, Figure 1 and 2). Therefore the ratio between the
thickness of the vessel lumen and the vessel wall was low-
ered in the OP group compared to YP (1.29 ± 0.05 vs. 3.29
± 0.15, p < 0.0001). The comparison of the same parame-
ters in ONHP vs. OHP showed no significant distinctions
(thickness of vessel wall: 3.13 ± 0.12 µm in ONHP vs.
3.16 ± 0.18 µm in OHP, n.s.; vessel lumen: 4.00 ± 0.26 µm
in ONHP vs. 4.00 ± 0.14 µm in OHP, n.s.; ratio: 1.28 ±
0.07 in ONHP vs. 1.30 ± 0.08 in OHP, n.s.)
Analysis of the thickness of the vessel wall and the inner  diameter of the vessel lumen in YP and OP Figure 1
Analysis of the thickness of the vessel wall and the 
inner diameter of the vessel lumen in YP and OP. Fig-
ure A indicates YP, Figure B indicates OP.
Analysis of the thickness of the vessel wall and the inner  diameter of the vessel lumen Figure 2
Analysis of the thickness of the vessel wall and the 
inner diameter of the vessel lumen. Black boxes indi-
cate YP. OP were divided into ONHP (grey boxes), and 
OHP (white boxes). The YP group revealed a significant thin-
ner vessel wall and a larger vessel lumen than OP (p < 
0.0001). No difference was observed between ONHP and 
OHP.BMC Neuroscience 2004, 5:37 http://www.biomedcentral.com/1471-2202/5/37
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Relative collagen type IV intensity in microvessels 
determined by CLSM
Analysis of the relative intensity of collagen type-IV posi-
tive vessels was performed by confocal laser scanning
microscopy. The relative content of collagen type IV in the
microvessel wall was higher in OP than in YP (233.1 ± 4.5
vs. 167.8 ± 10.6, p < 0.0001). Again, the intensity in non-
hypertensive old persons showed no difference compared
to hypertensive old patients (230.7 ± 4.2 vs. 234.3 ± 6.7,
n.s., Figure 3).
Discussion
In the present study, we investigated age- and hyperten-
sion-related alterations in the vascular extracellular matrix
and the basal lamina in human brains. Our main finding
is the age-related change of the basal lamina component
collagen type IV. In old as compared to young individuals
we found a significant decrease of the vessel number con-
taining collagen type IV, a thickening of the vessel wall
and narrowing of the vessel lumen and an increase in col-
lagen type IV content per vessel. These changes in extracel-
lular matrix proteins were demonstrated by
immunohistochemistry as well as by confocal laser scan-
ning microscopy. However, we were unable to establish
significant changes of the microvessels in hypertensive old
persons compared to normotensive old patients.
These results are in good accordance with previous studies
that have shown basal lamina thickening in experimental
studies [10-12]. Research on basal lamina changes in
humans has mostly been focused on their relationship to
neurodegeneration. In Alzheimer's patients Kalaria and
coworkers found a 55% increase of collagen type IV con-
tent in cerebral microvessels in comparison to age-
matched controls [13]. Farkas and colleagues described
collagen accumulation in the basal lamina of Parkinson's
disease [14]. Data about changes in the cerebral microvas-
culature in normal aging, however, are scarce. One study
examined cerebral microvessels in human neocortex, yet
failed to demonstrate an age-related thickening of the
basal lamina [15], however one study was able to show a
decrease of microvascular density by age in the hypotha-
lamus [4], interestingly also this study failed to show
hypertension related changes. One explanation for the
decreased microvascular density in the putamen might be
a reduced neoangiogenesis in the aging human brain, this
hypothesis should be examined in further studies.
One reason for the inconclusive findings in human cere-
bral microvessels might be the local origin of the samples,
as up to now rarefaction was only found in the deep grey
matter. The microvasculature is organized differently in
the basal ganglia than in the cortex. The basal ganglia
microvasculature has the geometry of a tree-like vascular
bed, in contrast the cortical microvascular networks are
rather organized like a grid structure [16]. Due to this rea-
son the deep grey matter might be more vulnerable to
metabolic changes in age, with reduced capabilities for
neoangiogenesis, as this might compensatory occur in
cortical areas. Therefore differential patterns of microvas-
cular changes within the brain might occur, resulting in
controversial results of microvascular density in the aging
brain. Another explanation seems to be a methodological
one. As the region of interest in putaminal sections can be
exactly defined from section to section, analyses of corti-
cal areas might be more problematic resulting in an
imprecise definition of comparable areas [15].
The reasons for the alterations of vascular extracellular
matrix proteins in aging are largely unknown. Not only
age is associated with an increase of extracellular matrix
proteins, as these changes were observed in several dis-
eases, like hypertension, brain tumors [17], HIV-encepha-
lopathy [18], Alzheimer's [13] or Parkinson's disease [14].
One explanation for the extracellular matrix accumula-
tion might be the reduction of the proteolytic systems
activity. The matrix metalloproteinases (MMP) and the
natural tissue endogenous inhibitors (TIMP), as well as
the plasminogen/plasmin system are involved in the reg-
ulation of ECM metabolism [19,20], and changes in these
proteases activity may contribute to vascular remodelling
in age by modulating the extracellular matrix
components. Therefore a reduction of these proteases
might result in a decreased turnover of the basal lamina
with a consecutive increase of these components. The
Analysis of the relative collagen type IV content in the micro- vessels by CLSM Figure 3
Analysis of the relative collagen type IV content in 
the microvessels by CLSM. The difference was significant 
between YP and OP (not shown), but not between ONHP 
and OHP.BMC Neuroscience 2004, 5:37 http://www.biomedcentral.com/1471-2202/5/37
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reduction of MMP activity by age was recently shown in
an experimental study [21] and in humans by antihyper-
tensive treatment [22], however studies about the role of
these proteases in the aging human brain are lacking and
the impact has to be evaluated in further studies.
The strength of our study is the combination of several dif-
ferent methods for the detection of basal lamina changes.
Even if the study by Abernethy and colleagues [4] was the
first one, that showed age related changes in the deep grey
matter, their study has some limitations. First they used a
nonspecific staining technique with alkaline phosphatase,
and second no detailed morphometric analysis of the ves-
sels or changes of the basal lamina were performed. On
the other hand, previously published studies most often
used only one method for the determination of microvas-
cular changes. For example the analyses of the vessel wall
and lumen was widely used as the only parameter. [23-25]
Unquestionably this method has a subjective approach
and therefore we see our results of the increased vessel
wall/lumen ratio in aging as a confirmation of previous
results. But in contrast to these studies our approach
employed an additional variety of complementary meth-
ods to examine the increase of basal membrane compo-
nents: number of vessels, total stained area of collagen
type IV, relative collagen type IV content per vessel and rel-
ative immunofluorescence by CLSM, all indicating into
the same direction.
Some methodological issues have to be discussed, starting
with the unexpected lack of a difference between old nor-
motensive and old hypertensive patients. One explana-
tion might be due to silent hypertension in the ONHP
group, as well as treated hypertension in the OHP group.
We tried to minimize this problem due to carefully study
of the case records in all patients. In addition in our study
hypertension was defined as a history of hypertension,
rather than the actual blood pressure in hospital, as these
patients with severe diseases might not had representative
blood pressure values in their last days or weeks of life
than decades before. On the other hand another study
failed to show the impact of hypertension on microvascu-
lar densitiy in a neuropathological study of the human
hypothalamus [4]. This unexpected lack of hypertension
related changes in the microvessels should be regarded as
preliminary, as neither the duration of hypertension nor
the effectiveness of treatment was considered.
Conclusions
The present data show age-related changes of the cerebral
microvessels in sections of human putamen for the first
time. Due to the accumulation of collagen, microvessels
thicken and show a reduction in their lumen. Besides this,
the number of vessels decreases. These findings might rep-
resent a precondition for the development of vascular cog-
nitive impairment.
Methods
The study was performed on 27 post-mortem human
brain samples from the putamen, which were taken from
autopsy. The clinical diagnoses were confirmed by routine
pathology and are shown in the table. Two groups of sub-
jects were compared: first young patients, all without a
history of hypertension (YP; n = 11, mean age 38.8 ± 6.8
years), and old patients (OP, n = 16, mean age 73.9 ± 4.1
years). The old patients were divided into two subgroups,
those without a history of hypertension (ONHP, n = 8,
mean age 73.1 ± 4.9 years), and those with a history of
hypertension (OHP, n = 8, mean age 74.6 ± 3.4 years).
There were no significant differences in age between OHP
and ONHP and in sex between YP and OP, as well as
between ONHP and OHP (see Table 1).
Table 1: Charactistics and cause of death
Young patients Old non-hypertensive pat. Old hypertensive patients
No Age Cause of death Sex No Age Cause of death Sex No Age Cause of death Sex
1 40 Bronchial carcinoma f 12 68 Lung embolism f 20 81 Gastric hemorrhage f
2 37 Malignant melanoma f 13 67 Lymphoma F 21 70 Pneumonia f
3 27 Lung embolism f 14 82 Mamma-carcinoma f 22 77 Peritonitis f
4 42 Leukemia f 15 71 Lymphoma F 23 74 Resp. insufficiency m
5 34 HIV f 16 77 Liver cirrhosis f 24 72 Bypass surgery m
6 40 Bronchial carcinoma f 17 72 Heart-lung insuff. m 25 74 Hepatorenal syndr. m
7 30 Aplastic anemia f 18 74 Sigmoid-carcinoma m 26 76 Sigmoid-carcinoma f
8 47 Leukemia m 19 74 Stomach-carcinoma m 27 73 Plasmacytoma f
9 44 Aortic aneurysm m
10 49 Hodgkin' disease m
11 37 Leukemia fBMC Neuroscience 2004, 5:37 http://www.biomedcentral.com/1471-2202/5/37
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The putamen either of the right or left side were removed
completely and fixated in paraffin. We chose the putamen
region, as it is easily to define and vascular changes and
strokes are predominantly located in this area. The blocks
were cut cross sectional in the same anterior-posterior
direction resulting in axial sections with a thickness of 10
µm. The sections were deparaffinized and immersed at
37°C in 0.4% Pepsin (Sigma, Germany) in 0.01 N HCl for
one hour. Collagen IV-positive vessels were stained with a
monoclonal mouse anti-collagen-IV antibody (Sigma,
Germany). Each section was incubated with 150 µl of the
primary antibody solution (at a concentration of 1:200)
for two hours at 37°C followed by incubation with bioti-
nylated secondary antibody against mouse IgG for 30
minutes at 37°C (Vector Laboratories). Vectastain ABC
reagent was added for 30 minutes at 37°C. Chromogen
(AEC Kit Biomeda Corp.) was used to develop the perox-
idase signal. Negative and positive controls were routinely
performed in each staining experiment. The same proce-
dure was used for immunofluorescence staining. Instead
of using the Vectastain ABC kit containing avidin, avidin
marked FITC (Dianova, Hamburg, Germany) was added
for 30 minutes at a dilution of 1:100.
The number of peroxidase stained vessels was determined
with the aid of a computerized video imaging system at a
magnification of ×100 (Optimas Version 6.5 from Media
Cybernetics, Silver Spring, USA). Only vessels smaller
than 30 µm were included. Total area of collagen IV posi-
tive vessels in the sections was analyzed using the same
system. Results are presented in arbitrary units. To obtain
the relative amount of collagen type IV per vessel the area
of collagen type IV was divided by the number of stained
vessels per microscopic field ([collagen type IV/micro-
scopic field]/[vessels/microscopic field]) The size of the
observed microscopic field was 150 × 200 µm.
To estimate microvessel hypertrophy, the ratio between
the diameter of vessel lumen and vessel wall, respectively,
was calculated semiquantitatively with the help of a sec-
ond computerized video imaging system (Medmo, Hom-
burg, Germany). Twenty entire cross-sectional
microvessels from the putamen were randomly selected at
a magnification of ×400. To calculate the wall to lumen
ratio, average distances of vessel wall and vessel lumen
were selected.
Fluorescence intensity measurements of microvessel-asso-
ciated FITC anti-mouse IgG against the anti-collagen anti-
body were performed with confocal laser scanning
microscopy (CLSM, Leica, Heidelberg, Germany). All
measurements were performed with the same pinhole
size, brightness and contrast, zoom, and laser time. Each
vessel was scanned in the z plane (10 scans per 1 µm), and
a summed image was calculated. Also, a summed image
was obtained from the background area to normalize the
local intensity to the background. The normalized inten-
sity is expressed as mean ± SEM for each microvessel using
a scale from 0 to 255 arbitrary units (U). The technique
was adopted from Hamann et al [26]. Twenty randomly
selected microvessels each of 7.5 to 30 µm in diameter of
the putamen were measured in each specimen.
Statistical analysis
Data are presented as mean +/- standard error of mean.
Statistical evaluations were performed using t-test.
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